Home » Stocks » Predictive Oncology

Predictive Oncology Inc. (POAI)

Stock Price: $1.57 USD -0.13 (-7.65%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
After-hours: $1.54 -0.03 (-1.91%) Aug 11, 7:59 PM

Stock Price Chart

Key Info

Market Cap 22.77M
Revenue (ttm) 1.45M
Net Income (ttm) -20.63M
Shares Out 14.50M
EPS (ttm) -5.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $1.57
Previous Close $1.70
Change ($) -0.13
Change (%) -7.65%
Day's Open 1.53
Day's Range 1.50 - 1.60
Day's Volume 1,877,065
52-Week Range 1.25 - 6.50

More Stats

Market Cap 22.77M
Enterprise Value 26.28M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 14.50M
Float 8.27M
EPS (basic) -6.28
EPS (diluted) -5.67
FCF / Share -1.99
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 186,753
Short Ratio 0.20
Short % of Float 1.33%
Beta 1.62
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 15.69
PB Ratio 2.10
Revenue 1.45M
Operating Income -28.27M
Net Income -20.63M
Free Cash Flow -9.66M
Net Cash -3.51M
Net Cash / Share -0.24
Gross Margin 60.62%
Operating Margin -1,948.24%
Profit Margin -1,441.30%
FCF Margin -665.81%
ROA -54.68%
ROE -395.70%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue1.411.410.650.460.650.950.470.190.10-
Revenue Growth-0.01%115.57%43.45%-30.24%-31.23%103.27%147.98%95.34%33454.51%-
Gross Profit0.881.000.510.270.350.570.280.060.04-
Operating Income-26.62-8.30-6.06-6.53-4.40-6.47-8.93-7.16-4.11-2.35
Net Income-19.39-10.09-6.00-6.53-4.79-6.83-9.41-7.42-4.49-1.35
Shares Outstanding2.871.280.640.280.020.010.01---
Earnings Per Share-6.86-7.87-9.40-23.10-308.60-572.50-1,160.00-2,063.02-3,375.84-2,063.02
Operating Cash Flow-8.73-5.29-4.46-4.38-7.49-3.37-3.86-1.18-1.78-0.82
Capital Expenditures-0.01-0.18-0.05-0.03-0.03-0.10-0.16---
Free Cash Flow-8.74-5.47-4.50-4.41-7.52-3.47-4.02-1.18-1.78-0.82
Cash & Equivalents0.150.661.682.154.860.020.100.010.120.01
Total Debt5.531.63---0.940.281.171.691.07
Net Cash / Debt-5.37-0.981.682.154.86-0.92-0.18-1.16-1.56-1.06
Assets22.383.713.622.815.630.900.590.370.450.17
Liabilities11.143.660.931.881.526.423.813.673.152.36
Book Value11.230.052.690.924.11-5.52-3.22-3.30-2.70-2.19
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Predictive Oncology Inc.
Country United States
Employees 29
CEO Carl Schwartz

Stock Information

Ticker Symbol POAI
Stock Exchange NASDAQ
Unique Identifier NASDAQ: POAI

Description

Predictive Oncology Inc. provides various healthcare products and services primarily in the United States. The company operates in three segments: Domestic, International, and Helomics. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers STREAMWAY System, a wall-mounted fully automated system that disposes suction fluid providing uninterrupted performance for physicians while virtually eliminating healthcare workers' exposure to infectious fluids collected during surgical and other patient procedures, as well as provides proprietary cleaning fluid and filters for use with STREAMWAY System. The company also provides data and artificial intelligence (AI) driven contract research organization (CRO) services for clinical and translational research; a range of multi-omics assays; and AI driven predictive models for the discovery of targeted therapies. Its CRO services enhance the effectiveness of cancer therapy using the power of artificial intelligence applied to diseases databases. The company sells its medical device products directly to hospitals and other medical facilities through employed sales representatives, independent contractors, and distributors. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was founded in 2002 and is based in Eagan, Minnesota.